Coronavirus: How Does Mask Prevent Droplets Spreading?

Coronavirus: How Does Mask Prevent Droplets Spreading?

Due to the cultural differences in wearing masks, it is very difficult for Europeans and Americans to wear masks because in their mind only those sick person need to wear masks to avoid infecting others. However, the novel coronavirus has many new features, such as a considerable number of asymptomatic infected people, and these infected people have a certain degree of infectivity. The asymptomatic patient does not know that he/her is infected with the virus, and go out or talk without wearing a mask, which is a risk to others .
Coronavirus: 7 Toolkit to Have a Safe Return-to-work

Coronavirus: 7 Toolkit to Have a Safe Return-to-work

Recently, many country government started to unveil their own progressively return-to-work plan in their countries at the end of April. From the statistics of coronavirus confirmed and deaths, the outbreak seems reach a platform now, and the trend of the spread looks be contained and get slower soon. With pressure of economy and unemployment, it is the have-to choice and decision to the government. Despite of whatever the situation of the epidemic, and the background of reopening, every one who have to be go back to work should to know how to protect himself/herself and the others around in same workplace from infection of coronavirus.
Coronavirus: Eat More High-Protein Foods Against Coronavirus

Coronavirus: Eat More High-Protein Foods Against Coronavirus

Since the outbreak of the novel coronavirus pneumonia epidemic, WHO, CDC and many experts have proposed that wearing masks, washing hands, ventilating, and maintaining social distance are most helpful to protect self and prevent from infection of coronavirus. And in every time speaking in public, they will always emphasize those again and again. But something might be missed obviously. We always focus on the outer factors which may cause coronavirus infect, how about to strengthen personal Immunity and resistance to the virus?
Coronavirus: Antibody Testing Becomes Much More Important for 'Immunity Passport'

Coronavirus: Antibody Testing Becomes Much More Important for 'Immunity Passport'

The pandemic of the novel coronavirus has spread to 210 countries and regions. The number of confirmed in the world is close to 3 million, and the number of deaths has exceeded 200,000. The epidemic has also caused the global economy to stall. Unemployment and economic depression have caused many countries to fall into the biggest economic crisis in past century. In Europe and the United States, where the epidemic is most severe, last week, the number of single-day deaths has continued to decrease, and governments have begun to consider gradually relaxing restrictions, reopening economic producing and social activities while continuing to prevent the outbreak of the second wave of outbreaks.
Coronavirus: Antibody test Kit and Nucleic Acid Test Kit

Coronavirus: Antibody test Kit and Nucleic Acid Test Kit

Brief Difference between Nucleic Acid Test kit and Antibody Test Kit. Nucleic Acid Test Kit What is Nucleic Acid Test (NAT) and how it works may be find in this article: What is Nucleic Acid Detection?. In this article, just compare the difference of Nucleic Acid Test and Antibody Test. Nucleic Acid Test currently is the main diagnostic test method to check and confirm the suspected Coronavirus patients, because it has strong specificity and relatively high sensitivity by detecting the existence of the viral nucleic acid in our collected specimen directly.
Coronavirus: WHO: No Immunity Passport, Antibody Could Not Protect From a Second Infection

Coronavirus: WHO: No Immunity Passport, Antibody Could Not Protect From a Second Infection

Recently, some governments suggested that the detection of antibodies to the Coronavirus (COVID-19), could be taken as an “immunity passport” or “risk-free certificate”. In this case, those with COVID-19 antibody could be able to travel or to return to work with the assumption that they are protected against re-infection. And this also is the basis of “Group Immunity” strategy in some Europe countries. There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from re-infection.
Coronavirus: Reopening and Trump's Making America Great Again

Coronavirus: Reopening and Trump's Making America Great Again

“It is a target, and, obviously, we’re hopeful about that target, but I think it’s just too early to be able to tell that we see light at the end of the tunnel,” Food and Drug Administration Commissioner Stephen Hahn said on ABC News’s “This Week”. Last week, what as discussed most is the president Trump’s decision of Reopening economy and Returning to work by lift lockdown policy progressively. Is whole USA ready?
Coronavirus: Why Could China Suppress COVID-19 So Fast? The Secrete is CHINA.

Coronavirus: Why Could China Suppress COVID-19 So Fast? The Secrete is CHINA.

Coronavirus has been the hottest topic of the world now. The confirmed number and deaths are keep growing up, and every one is waiting the peak coming. But when, no one knows. At least, from the statistics the growth rate is not getting slower. In this case, many people may have doubts why China could contain and suppress Coronavirus so quickly in a short time, clean the cases to zero and lift the lockdown soon.
Coronavirus: Can COVID-19 Vaccine Eliminate Coronavirus Entirely?

Coronavirus: Can COVID-19 Vaccine Eliminate Coronavirus Entirely?

WHO recently led to establish a global vaccine research team composed of scientists, doctors, funders and manufacturers. The WHO statement stated that this would help reduce inefficiency and duplication of labor. Earlier, the document issued by the WHO on April 11 stated that there were three vaccines that had entered clinical trials globally. There are 67 vaccines that have not yet entered clinical trials. According to the State Council of China, China is researching and developing in five technical directions including inactivated vaccines, genetically engineered recombinant subunit vaccines, adenovirus vector vaccines, attenuated influenza virus vector vaccines, and nucleic acid vaccines.
Coronavirus: COVID-19 Vaccine By Oxford University Will Begin Human Body Trials On Thursday (2020/04/21)

Coronavirus: COVID-19 Vaccine By Oxford University Will Begin Human Body Trials On Thursday (2020/04/21)

On April 23, a novel coronavirus vaccine developed by the University of Oxford in the United Kingdom began human clinical trials. At the same time, the United Kingdom began to manufacture about 1 million doses of vaccines. It is hoped that the clinical trial results coming out this fall will prove the safety of those 1 million vaccines. Reported on the website of Newsweek (newsweek.com) in the United States on April 21, at a press conference held that afternoon, British Health Secretary Matthew Hancock said that two vaccines developed by British researchers have made significant progress, and one of which was ready to begin human trials on Thursday which was developed by Oxford University researchers.